Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center.

[1]  J. González,et al.  Análisis genético de las mutaciones de RET en las familias con neoplasia endocrina múltiple tipo 2 de la Comunidad de Murcia , 1999 .

[2]  H. K. V. van Amstel,et al.  Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children. , 1999, Journal of pediatric surgery.

[3]  T. van Vroonhoven,et al.  [Prophylactic total thyroidectomy in childhood for multiple endocrine neoplasia type 2A: preliminary results]. , 1999, Nederlandsch tijdschrift voor geneeskunde.

[4]  R. Hinze,et al.  Primary hereditary medullary thyroid carcinoma – C-cell morphology and correlation with preoperative calcitonin levels , 1998, Virchows Archiv.

[5]  R. Hinze,et al.  Prophylactic Thyroidectomy in 75 Children and Adolescents with Hereditary Medullary Thyroid Carcinoma: German and Austrian Experience , 1998, World Journal of Surgery.

[6]  L. Gaboury,et al.  Prophylactic thyroidectomy for medullary thyroid carcinoma in gene carriers of MEN2 syndrome. , 1998, Journal of pediatric surgery.

[7]  H. Buhr,et al.  Prophylactic thyroidectomy in MEN IIA: does the calcitonin level correlate with tumor spread? , 1998, Langenbeck's Archives of Surgery.

[8]  H. Gharib,et al.  Advances and controversies in the diagnosis and management of medullary thyroid carcinoma. , 1997, The American journal of medicine.

[9]  R. Simó,et al.  False-positive results of basal and pentagastrin-stimulated calcitonin in non-gene carriers of multiple endocrine neoplasia type 2A. , 1997, Thyroid : official journal of the American Thyroid Association.

[10]  R. DeLellis.  C‐Cell Hyperplasia: A Current Perspective , 1997 .

[11]  C Eng,et al.  The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. , 1996, JAMA.

[12]  S. Pilotti,et al.  Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid: A retrospective study of 109 consecutive patients , 1996, Cancer.

[13]  T. Lairmore,et al.  Genetic testing and early thyroidectomy for inherited medullary thyroid carcinoma. , 1996, Annals of medicine.

[14]  M. Sironi,et al.  Multivariate analysis of patients with medullary thyroid carcinoma: Prognostic significance and impact on treatment of clinical and pathologic variables , 1996, Cancer.

[15]  A. Pinchera,et al.  Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations. , 1995, Surgery.

[16]  B. Franc,et al.  C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases. , 1994, Human pathology.

[17]  A. Grauer,et al.  Multiple endocrine neoplasia type 2. Clinical features and screening. , 1994, Endocrinology and metabolism clinics of North America.

[18]  S. Wells,et al.  Current perspectives on the diagnosis and management of patients with multiple endocrine neoplasia type 2 syndromes. , 1994, Endocrinology and metabolism clinics of North America.

[19]  A. E. Boyd,et al.  Management of individual tumor syndromes. Medullary thyroid carcinoma and hyperparathyroidism. , 1994, Endocrinology and metabolism clinics of North America.

[20]  B. Ponder,et al.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.

[21]  A. Pinchera,et al.  Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens. , 1991, American journal of clinical pathology.

[22]  A H Tashjian,et al.  The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. , 1988, The New England journal of medicine.

[23]  A. Tashjian,et al.  C-cell hyperplasia preceding medullary thyroid carcinoma. , 1973, The New England journal of medicine.

[24]  S. Wells,et al.  Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. , 1996, Surgery.